• KeyBanc initiated coverage on Zoetis Inc. (NYSE:ZTS) with a "Sector Weight" rating, indicating expectations of performance in line with the broader sector.
• Zoetis to participate in the Piper Sandler 37th Annual Healthcare Conference, with CEO Kristin Peck and CFO Wetteny Joseph addressing company strategies and performance.
• The stock price of Zoetis has seen fluctuations, with a year high of $181.85 and a low of $115.25, reflecting its significant market presence with a market capitalization of approximately $51.07 billion.

Zoetis Inc. (NYSE:ZTS) is a leading global animal health company that develops, manufactures, and markets veterinary vaccines and medicines. The company serves veterinarians, livestock producers, and pet owners. Zoetis competes with other major players in the animal health industry, such as Elanco Animal Health and Merck Animal Health.

On November 20, 2025, KeyBanc initiated coverage of Zoetis with a "Sector Weight" rating. At that time, the stock price was $115.89. This rating suggests that KeyBanc expects Zoetis to perform in line with the broader sector. The stock price reflects a decrease of 1.02%, dropping by $1.19 today.

Zoetis is set to participate in the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025. CEO Kristin Peck and CFO Wetteny Joseph will represent the company. They will address questions from analysts, providing insights into the company's strategies and performance. Investors can listen to the live audio webcast on the Zoetis investor website.

The stock price of ZTS has fluctuated between $115.80 and $118.43 during the trading day. Over the past year, the stock has seen a high of $181.85 and a low of $115.25. The company's market capitalization is approximately $51.07 billion, indicating its significant presence in the market. Today's trading volume for ZTS is 3,260,584 shares.